AP
BDSI

Atwood & Palmer’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Atwood & Palmer’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,000
Closed -$4K – 354
2016
Q4 		$4K Hold
2,000
– – ﹤0.01% 302
2016
Q3 		$5K Buy
+2,000
New +$5.08K ﹤0.01% 291

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Atwood & Palmer's BDSI Position: Q1 2017 in Review

Atwood & Palmer sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2017, closing a stake of 2,000 shares — an estimated $4K sold.

Atwood & Palmer first reported a position in BDSI in Q3 2016 and held it in 2 quarters. The position peaked at $5K in Q3 2016. 63 funds tracked by Wall St. Rank hold BDSI as of Q1 2017.

  • Atwood & Palmer reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2017 after selling out during the quarter.
  • Atwood & Palmer sold 2,000 BioDelivery Sciences International, Inc. shares in Q1 2017, an estimated $4K.
  • Atwood & Palmer first reported a position in BioDelivery Sciences International, Inc. in Q3 2016 and held it in 2 quarters.
  • Atwood & Palmer's BioDelivery Sciences International, Inc. position peaked at $5K in Q3 2016.
  • 63 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2017.

Based on Atwood & Palmer's 13F filing for Q1 2017, filed 28 Apr 2017.